Global In Silico Clinical Trials Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global In Silico Clinical Trials Market Research Report 2024
An in silico clinical trial, also known as a virtual clinical trial, is an individualized computer simulation used in the development or regulatory evaluation of a medicinal product, device, or intervention. While completely simulated clinical trials are not feasible with current technology and understanding of biology, its development would be expected to have major benefits over current in vivo clinical trials, and research on it is being pursued.
According to MRAResearch’s new survey, global In Silico Clinical Trials market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Silico Clinical Trials market research.
Key companies engaged in the In Silico Clinical Trials industry include Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., Dassault Systemes SE, GNS Healthcare Inc., The AnyLogic Company, InSilicoTrials, Immunetrics Inc. and Nuventra Pharma Sciences, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of In Silico Clinical Trials were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole In Silico Clinical Trials market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In Silico Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Certara, Inc.
Novadiscovery Sas
Insilico Medicine, Inc.
Dassault Systemes SE
GNS Healthcare Inc.
The AnyLogic Company
InSilicoTrials
Immunetrics Inc.
Nuventra Pharma Sciences
Abzena Ltd.
Siemens
Segment by Type
Phase I
Phase II
Phase III
Phase IV
Oncology
Infectious Disease
Hematology
Cardiology
Dermatology
Neurology
Diabetes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In Silico Clinical Trials report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global In Silico Clinical Trials market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Silico Clinical Trials market research.
Key companies engaged in the In Silico Clinical Trials industry include Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., Dassault Systemes SE, GNS Healthcare Inc., The AnyLogic Company, InSilicoTrials, Immunetrics Inc. and Nuventra Pharma Sciences, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of In Silico Clinical Trials were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole In Silico Clinical Trials market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In Silico Clinical Trials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Certara, Inc.
Novadiscovery Sas
Insilico Medicine, Inc.
Dassault Systemes SE
GNS Healthcare Inc.
The AnyLogic Company
InSilicoTrials
Immunetrics Inc.
Nuventra Pharma Sciences
Abzena Ltd.
Siemens
Segment by Type
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Oncology
Infectious Disease
Hematology
Cardiology
Dermatology
Neurology
Diabetes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In Silico Clinical Trials report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source